Skip to content
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Heart icon (animated) heart icon (static)
Our Stories
Our Company
Explore more Johnson & Johnson sites:
China
France
Germany
India
Japan
Russia
Switzerland
German
English
French
United Kingdom
United States
Share

Investor Information

Get the latest news, conference announcements, press releases and company performance information to be an informed shareholder.
Johnson & Johnson Chairman of the Board and CEO Joaquin Duato speaking to a live audience
2023 Annual Meeting of Shareholders
2023 Annual Meeting of Shareholders
Annual Meeting Materials and Webcast
A photo of a Johnson & Johnson signature brick
Consumer Health Separation: Johnson & Johnson Shareholder Frequently Asked Questions
Consumer Health Separation: Johnson & Johnson Shareholder Frequently Asked Questions
Learn More

Latest News Releases

See All News Releases
ON NOW Webcast: Pharmaceutical Business Review 2021
Webcast: Pharmaceutical Business Review 2021
Webcast: Pharmaceutical Business Review 2021
ON NOW 2021 Health for Humanity Report
2021 Health for Humanity Report
2021 Health for Humanity Report
ON NOW 2022 Janssen U.S. Transparency Report
2022 Janssen U.S. Transparency Report
2022 Janssen U.S. Transparency Report
ON NOW 2022 Annual Report
2022 Annual Report

Investor Relations

Investor FAQs
Answers to common questions regarding purchasing and owning Johnson & Johnson stock.
Learn More
ESG Resources
Effective management of ESG matters is a business imperative.
Learn More
Contact Investor Relations
Questions? Please contact us:
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue